Global Demand For MRI-Guided Neurosurgical Ablation Systems Is Expected To Reach A Market Valuation Of US$ 1.29 Billion By 2033
The MRI-guided neurosurgical ablation market refers to the market for medical devices and technologies used for performing ablation procedures in the brain, using MRI (magnetic resonance imaging) guidance. Ablation is a minimally invasive procedure that uses heat or cold to destroy or remove abnormal tissue in the brain. MRI-guided neurosurgical ablation is a rapidly evolving field that offers many benefits over traditional surgical methods, including reduced risk of infection, shorter recovery times, and improved accuracy.
The market for MRI-guided neurosurgical ablation devices and technologies is expected to grow rapidly in the coming years, driven by the increasing prevalence of neurological disorders such as brain tumors, epilepsy, and Parkinson’s disease. Other factors driving market growth include technological advancements in MRI-guided ablation devices, increasing awareness among patients and healthcare providers about the benefits of minimally invasive procedures, and the availability of reimbursement for these procedures in many countries.
Major players in the MRI-guided neurosurgical ablation market include Medtronic, Inc., Insightec Ltd., AngioDynamics, Inc., Monteris Medical, Inc., and MRI Interventions, Inc. These companies are investing heavily in research and development to develop new and innovative products and technologies that offer greater precision, efficiency, and safety in neurosurgical ablation procedures.
Get a Free Sample PDF of this Research Report https://www.factmr.com/connectus/sample?flag=S&rep_id=8318
Key findings of the MRI-guided Neurosurgical Ablation market study:
- The report provides a present market outlook on MRI-guided Neurosurgical Ablation. Additionally, the MRI-guided Neurosurgical Ablation market share is anticipated to grow with a CAGR of 8% in the forecast period.
- Regional breakdown of the MRI-guided Neurosurgical Ablation market based on predefined taxonomy.
- Innovative manufacturing processes implemented by MRI-guided Neurosurgical Ablation vendors in detail.
- Region-wise and country-wise fragmentation of the MRI-guided Neurosurgical Ablation market to grasp the revenue, and growth outlook in these areas.
- Changing preferences among consumers across various regions and countries.
- Factors (Positive and Negative) impacting the growth of the global MRI-guided Neurosurgical Ablation market.
- MRI-guided Neurosurgical Ablation price, market share, and Trends forecast for assessment period 2023-2033
Why Do Hospitals Dominate the Sales of MRI-guided Neurosurgical Ablation Systems?
Hospitals dominate the sales of MRI-guided neurosurgical ablation systems for several reasons:
- Access to Patients: Hospitals have access to a large pool of patients who require neurosurgical interventions, including those who may benefit from MRI-guided neurosurgical ablation. The hospitals’ network of physicians and specialists enables them to identify patients who are suitable candidates for this technology.
- Expertise: Hospitals have experienced and skilled physicians who are well-versed in performing neurosurgical procedures, including MRI-guided ablation. These physicians have the necessary training and expertise to operate advanced equipment like MRI-guided neurosurgical ablation systems.
- Infrastructure: Hospitals have the infrastructure required to support the use of MRI-guided neurosurgical ablation systems, including dedicated MRI suites and operating rooms. They also have access to other advanced imaging and diagnostic technologies, which can aid in the pre-operative planning and post-operative follow-up.
- Reimbursement: Hospitals are typically able to secure reimbursement for the use of MRI-guided neurosurgical ablation systems, which can be a significant factor in driving sales. Insurance companies and government payers are more likely to reimburse hospitals than independent clinics or outpatient facilities.
- Regulatory Approval: Obtaining regulatory approval for medical devices like MRI-guided neurosurgical ablation systems can be a lengthy and expensive process. Hospitals are more likely to have the resources and expertise required to navigate the regulatory landscape, making it easier for them to bring these systems to market.
Competitive landscape analysis
Businesses are focusing on research and development to produce technologically advanced products in order to obtain a competitive edge. The primary goal of major market participants is to raise the bar for product quality.
- For instance, the ClearPoint PURSUIT Neuro Aspiration system for MRI Interventions, Inc., a neurosurgical company, was authorised by the U.S. FDA in January 2019. The aspiration of abscesses, cerebral spinal fluid, clots, and cystic tumours are the planned uses of this instrument, which was developed in partnership with the Mayo Clinic.
- A similar announcement was made by Medtronic in April 2018 about the rollout of the Visualase MRI-Guided Laser Ablation System across Europe. The brain disorders that are to be treated with this minimally invasive laser therapy are precisely targeted and treated in small areas of unwanted tissue.
Some of the leading companies operating in the market are :
- AngioDynamics Inc
- Boston Scientific Corporation
- Insightec Ltd
- Medtronic PLC
- Monteris Medical Inc
- MRI Intervention Inc.
What insights does the MRI-guided Neurosurgical Ablation report provide to the readers?
- MRI-guided Neurosurgical Ablation fragmentation on the basis of product type, end use, and region.
- Comprehensive assessment of upstream starting materials, downstream demand, and present market landscape.
- Collaborations, R&D projects, acquisitions, and product launches of each MRI-guided Neurosurgical Ablation
- Various regulations imposed by the governments on the consumption of MRI-guided Neurosurgical Ablation in detail.
MRI-guided Neurosurgical Ablation Industry Research Segments
· By Product :
-
- RF Ablation Systems
- Laser Ablation Systems
- Focused Ultrasound Systems
- Accessories
· By End User :
-
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Research Laboratories
· By Region :
-
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
For in-depth competitive analysis, Buy Now – https://www.factmr.com/checkout/8318
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com
This Press Release has been written with the intention of providing accurate market information which will enable our readers to make informed strategic investment decisions. If you notice any problem with this content, please feel free to reach us on mediarelations@xherald.com.
The post Global Demand For MRI-Guided Neurosurgical Ablation Systems Is Expected To Reach A Market Valuation Of US$ 1.29 Billion By 2033 appeared first on X herald.
Xherald
